Nexans entre en négociations exclusives avec Latour Capital pour la vente de Lynxeo
Nexans entre en négociations exclusives avec Latour Capital pour la vente de Lynxeo _COMMUNIQUE DE PRESSE_ Nexans annonce être entré en négociations exclusives avec Latour Capital pour la vente de…
VEON appoints Johan Buse as the Incoming CEO of Banglalink
Dubai and Dhaka, 17 March 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or the “Group”), today announces that Johan Buse has been appointed as the Chief Executive…
Castellum Announces Pricing of $4.5 Million Public Offering of Common Stock and Warrants
VIENNA, Va., March 16, 2025 (GLOBE NEWSWIRE) -- Castellum, Inc. (the “Company” and “Castellum”) (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services company focused on the federal government, today…
Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRαME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025
SOUTH SAN FRANCISCO, Calif., March 15, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs),…
Qifu Technology Announces Fourth Quarter and Full Year 2024 Unaudited Financial Results and Raises Semi-Annual Dividend
SHANGHAI, China, March 16, 2025 (GLOBE NEWSWIRE) -- Qifu Technology, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qifu Technology” or the “Company”), a leading AI-empowered Credit-Tech platform in China, today announced its…
Dyne Therapeutics Announces New Long-Term Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy Demonstrating Unprecedented and Sustained Functional Improvement Through 18 Months
- Continued favorable safety profile for DYNE-251 - - DELIVER Registrational Expansion Cohort is fully enrolled; data from this cohort planned for late 2025 - - Potential for Biologics License…
Arch Biopartners Closes Non-Brokered Private Placement
TORONTO, March 14, 2025 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has closed a non-brokered private placement offering…
Nokia Corporation: Repurchase of own shares on 14.03.2025
Nokia CorporationStock Exchange Release14 March 2025 at 22:30 EET Nokia Corporation: Repurchase of own shares on 14.03.2025 Espoo, Finland – On 14 March 2025 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired…
Nokia Oyj: Omien osakkeiden takaisinosto 14.03.2025
Nokia OyjPörssitiedote14.03.2025 klo 22.30 Nokia Oyj: Omien osakkeiden takaisinosto 14.03.2025 Espoo – Nokia Oyj (LEI: 549300A0JPRWG1KI7U06) on 14.03.2025 hankkinut omia osakkeitaan (ISIN FI0009000681) omistukseensa seuraavasti: Markkinapaikka (MIC Code)Osakkeiden lukumääräPainotettu keskihinta…
SigmaTron International, Inc. Reports Financial Results for the Third Quarter of Fiscal 2025
ELK GROVE VILLAGE, Ill., March 14, 2025 (GLOBE NEWSWIRE) -- SigmaTron International, Inc. (NASDAQ: SGMA), an electronic manufacturing services company (the “Company”), today reported revenues and earnings for the fiscal…